Slide 1: Thomas Weisel Partners Healthcare Tailwinds
Exhibit 99 Thomas Weisel Healthcare September 8, Tailwinds 2004 Partners 2004
Slide 2: Forward-Looking Statements
Forward-Looking Except predictions set 8, occurrence 2 2004. forthfor We in historical the of and undertake unanticipated Company’s that Statements actual information no obligation events latest events. SEC discussed, or results toFilings publicly may today’s onrelease differ Forms presentation mate
Slide 3: Sales by Business Segment, Fiscal Year Ended March 31, 2004
Sales SCIENCES Fiscal HEALTHCARE LIFE 69% STERIS 23% 3 8% by Year ISOMEDIX Business Ended($753) ($246) Segment March SERVICES 31, 2004($88) (Dollars in millions)
Slide 4: Healthcare Segment Overview
Healthcare Equipment Products: Outpatient Hospitals Customers: Growth Aging Inpatient Sterile Surgical Others: Skin STERIS Competitive Integrated 4 Care—$300 population Processing—$3.6 Getinge, Drivers: Tables US key and offering surgical Segment and leader Position: Strengths player outpatient chem
Slide 5: Life Sciences Segment Overview
Lifehomeland Variety Products: products Pharmaceutical Customers: Growth Aging Increased Industry on STERIS manufacturers Competitive Breadth 5 Sciences population of Drivers: of investment has and drug equipment product aStrengths: Position: services defense Segment strong in consumption and a vari
Slide 6: Isomedix Services Segment Overview
Batch contract Products: Medical Customers: Growth Outsourcing Competitive STERIS Sterigenics Competitors: Broad Responsive Strengths: 6 capability/technology Drivers: device Isomedix US IBA leader Position: bysterilization manufacturers Surebeam Services in $690Cosmed in million Overview Strategica
Slide 7: Our Growth Strategy
Our Growth Enhance Increase 7 recurring our Strategy revenue revenues streamLeverage by continuing our channel to diversify Introduce by product, new technologies service, market Adaptand ourgeography technologies Expand internationally